One of the key presentations at the 2018 Pharmacovigilance and Drug Safety Summit in Berlin was from Dr. Sameer Thapar, Global Pharmacovigilance Director at Oracle Health Sciences Consulting, who gave two forward-thinking presentations about the use of cloud computing and artificial intelligence in pharmacovigilance.
With more than 60% of drug safety experts planning to use AI to improve processes, we’ll share why the general interest in AI is growing and how the industry has embraced other technologies such as the role of big data and cloud computing.
Here are some key learnings from Dr. Thapar’s presentation about merging these technologies and how they’re being used within PV and drug safety.
On June 14th and 15th, we hosted the inaugural Pharmacovigilance and Drug Safety Summit in Berlin which was received warmly by all attendees. Our intention was to host an executive conference that would address up-to-date regulatory changes, signal detection and new technology trends.